Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
South Korea
· Delayed Price · Currency is KRW 2,040.00
-95.00 (-4.45%)
Nov 15, 2024, 9:00 AM KST
Kangstem Biotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 13,278 | 12,704 | 16,301 | 12,405 | 9,138 | 6,005 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | -0 | - | -0 | Upgrade
|
| Revenue | 13,278 | 12,704 | 16,301 | 12,405 | 9,138 | 6,005 | Upgrade
|
| Revenue Growth (YoY) | 12.19% | -22.06% | 31.41% | 35.75% | 52.18% | -34.49% | Upgrade
|
| Cost of Revenue | 11,390 | 11,061 | 11,428 | 9,716 | 8,092 | 6,429 | Upgrade
|
| Gross Profit | 1,888 | 1,643 | 4,873 | 2,689 | 1,046 | -424.36 | Upgrade
|
| Selling, General & Admin | 9,421 | 10,272 | 11,076 | 10,636 | 6,799 | 9,994 | Upgrade
|
| Research & Development | 13,158 | 14,030 | 14,220 | 14,653 | 12,639 | 12,415 | Upgrade
|
| Operating Expenses | 22,675 | 24,420 | 25,431 | 25,424 | 19,771 | 22,729 | Upgrade
|
| Operating Income | -20,787 | -22,777 | -20,558 | -22,736 | -18,725 | -23,154 | Upgrade
|
| Interest Expense | -877.15 | -893.42 | -761.13 | -761.09 | -560.71 | -1,077 | Upgrade
|
| Interest & Investment Income | 1,543 | 1,534 | 1,218 | 742.09 | 882.08 | 426.12 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | -563.07 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.48 | -2.94 | 56.62 | 50.27 | 3.47 | 3.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 72.48 | 29.1 | 143.53 | -30.07 | 117.45 | 746.65 | Upgrade
|
| EBT Excluding Unusual Items | -20,054 | -22,110 | -19,901 | -22,734 | -18,283 | -23,618 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -1,711 | Upgrade
|
| Gain (Loss) on Sale of Investments | 8,402 | -872.13 | -308.46 | -348.21 | 298 | 2,022 | Upgrade
|
| Gain (Loss) on Sale of Assets | 98.51 | 95.52 | -5.6 | 1,272 | -19.19 | - | Upgrade
|
| Asset Writedown | -250.52 | -250.52 | - | - | -1,752 | -2,996 | Upgrade
|
| Pretax Income | -11,804 | -23,137 | -20,215 | -21,811 | -19,756 | -26,302 | Upgrade
|
| Income Tax Expense | 83.71 | 83.71 | -38.96 | 15.8 | -9.98 | 92.26 | Upgrade
|
| Earnings From Continuing Operations | -11,888 | -23,221 | -20,176 | -21,827 | -19,746 | -26,394 | Upgrade
|
| Minority Interest in Earnings | 962.08 | 1,272 | -59.78 | 478.45 | 1,274 | 1,760 | Upgrade
|
| Net Income | -9,765 | -21,949 | -20,236 | -21,348 | -18,471 | -24,635 | Upgrade
|
| Net Income to Common | -9,765 | -21,949 | -20,236 | -21,348 | -18,471 | -24,635 | Upgrade
|
| Shares Outstanding (Basic) | 50 | 41 | 38 | 28 | 22 | 21 | Upgrade
|
| Shares Outstanding (Diluted) | 50 | 41 | 38 | 28 | 22 | 21 | Upgrade
|
| Shares Change (YoY) | 30.75% | 7.02% | 36.23% | 24.89% | 6.99% | 13.71% | Upgrade
|
| EPS (Basic) | -196.85 | -540.61 | -533.40 | -766.61 | -828.42 | -1182.10 | Upgrade
|
| EPS (Diluted) | -196.85 | -540.61 | -533.40 | -766.61 | -828.42 | -1182.10 | Upgrade
|
| Free Cash Flow | -17,229 | -17,890 | -19,576 | -21,624 | -17,033 | -28,664 | Upgrade
|
| Free Cash Flow Per Share | -347.33 | -440.63 | -516.01 | -776.52 | -763.89 | -1375.45 | Upgrade
|
| Gross Margin | 14.22% | 12.93% | 29.89% | 21.68% | 11.44% | -7.07% | Upgrade
|
| Operating Margin | -156.55% | -179.29% | -126.12% | -183.28% | -204.92% | -385.60% | Upgrade
|
| Profit Margin | -73.54% | -172.77% | -124.14% | -172.10% | -202.14% | -410.26% | Upgrade
|
| Free Cash Flow Margin | -129.76% | -140.82% | -120.10% | -174.32% | -186.39% | -477.37% | Upgrade
|
| EBITDA | -17,050 | -18,862 | -16,688 | -18,862 | -15,732 | -21,056 | Upgrade
|
| EBITDA Margin | -128.41% | -148.47% | -102.37% | -152.05% | -172.16% | - | Upgrade
|
| D&A For EBITDA | 3,736 | 3,915 | 3,871 | 3,874 | 2,994 | 2,097 | Upgrade
|
| EBIT | -20,787 | -22,777 | -20,558 | -22,736 | -18,725 | -23,154 | Upgrade
|
| EBIT Margin | -156.55% | -179.29% | -126.12% | -183.28% | -204.92% | - | Upgrade
|
| Advertising Expenses | - | 199.08 | 533.74 | 589.25 | 80.83 | 858.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.